Literature DB >> 21240466

Integrated Testing Strategy (ITS) - Opportunities to better use existing data and guide future testing in toxicology.

Joanna Jaworska1, Sebastian Hoffmann.   

Abstract

The topic of Integrated Testing Strategies (ITS) has attracted considerable attention, and not only because it is supposed to be a central element of REACH, the ambitious European chemical regulation effort. Although what ITSs are supposed to do seems unambiguous, i.e. speeding up hazard and risk assessment while reducing testing costs, not much has been said, except basic conceptual proposals, about the methodologies that would allow execution of these concepts. Although a pressing concern, the topic of ITS has drawn mostly general reviews, broad concepts, and the expression of a clear need for more research on ITS. Published research in the field remains scarce. Solutions for ITS design emerge slowly, most likely due to the methodological challenges of the task, and perhaps also to it its complexity and the need for multidisciplinary collaboration. Along with the challenge, ITS offer a unique opportunity to contribute to the Toxicology of the 21st century by providing frameworks and tools to actually implement 21st century toxicology data in the chemical management and decision making processes. Further, ITS have the potential to significantly contribute to a modernization of the science of risk assessment. Therefore, to advance ITS research we propose a methodical approach to their design and will discuss currently available approaches as well as challenges to overcome. To this end, we define a framework for ITS that will inform toxicological decisions in a systematic, transparent, and consistent way. We review conceptual requirements for ITS developed earlier and present a roadmap to an operational framework that should be probabilistic, hypothesis-driven, and adaptive. Furthermore, we define properties an ITS should have in order to meet the identified requirements and differentiate them from evidence synthesis. Making use of an ITS for skin sensitization, we demonstrate how the proposed ITS concepts can be implemented.

Mesh:

Substances:

Year:  2010        PMID: 21240466     DOI: 10.14573/altex.2010.4.231

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  13 in total

1.  Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing.

Authors:  Raja S Settivari; Nicholas Ball; Lynea Murphy; Reza Rasoulpour; Darrell R Boverhof; Edward W Carney
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

2.  Integrated testing strategies for safety assessments.

Authors:  Thomas Hartung; Tom Luechtefeld; Alexandra Maertens; Andre Kleensang
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

3.  Building shared experience to advance practical application of pathway-based toxicology: liver toxicity mode-of-action.

Authors:  Catherine Willett; Jessica Caverly Rae; Katy O Goyak; Gary Minsavage; Carl Westmoreland; Melvin Andersen; Mark Avigan; Daniel Duché; Georgina Harris; Thomas Hartung; Hartmut Jaeschke; Andre Kleensang; Brigitte Landesmann; Suzanne Martos; Marilyn Matevia; Colleen Toole; Andrew Rowan; Terry Schultz; Jennifer Seed; John Senior; Imran Shah; Kalyanasundaram Subramanian; Mathieu Vinken; Paul Watkins
Journal:  ALTEX       Date:  2014-01-28       Impact factor: 6.043

Review 4.  Perspectives on In Vitro to In Vivo Extrapolations.

Authors:  Thomas Hartung
Journal:  Appl In Vitro Toxicol       Date:  2018-12-08

5.  A Web-based Alternative Non-animal Method Database for Safety Cosmetic Evaluations.

Authors:  Seung Won Kim; Bae-Hwan Kim
Journal:  Toxicol Res       Date:  2016-07-30

6.  Towards sensible toxicity testing for nanomaterials: proposal for the specification of test design.

Authors:  Annegret Potthoff; Mirco Weil; Tobias Meißner; Dana Kühnel
Journal:  Sci Technol Adv Mater       Date:  2015-12-09       Impact factor: 8.090

7.  Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructure.

Authors:  Stéphanie Boué; Thomas Exner; Samik Ghosh; Vincenzo Belcastro; Joh Dokler; David Page; Akash Boda; Filipe Bonjour; Barry Hardy; Patrick Vanscheeuwijck; Julia Hoeng; Manuel Peitsch
Journal:  F1000Res       Date:  2017-01-05

Review 8.  Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies.

Authors:  Lisa Accomasso; Caterina Cristallini; Claudia Giachino
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

9.  From "weight of evidence" to quantitative data integration using multicriteria decision analysis and Bayesian methods.

Authors:  Igor Linkov; Olivia Massey; Jeff Keisler; Ivan Rusyn; Thomas Hartung
Journal:  ALTEX       Date:  2015       Impact factor: 6.043

Review 10.  Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program.

Authors:  Patience Browne; Pamela D Noyes; Warren M Casey; David J Dix
Journal:  Environ Health Perspect       Date:  2017-09-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.